ストックスクリーナーアプリを入手
5.94
4.95%
0.28
アフターアワーズ：
5.93
-0.01
-0.17%
前日終値:
$5.66
開ける：
$5.63
24時間の取引高:
141.80K
Relative Volume:
0.54
時価総額：
$229.26M
収益：
$14.79M
当期純損益:
$-96.02M
株価収益率:
-0.9617
EPS:
-6.1766
ネットキャッシュフロー:
$-95.70M
1週間 パフォーマンス:
+4.39%
1か月 パフォーマンス:
-9.73%
6か月 パフォーマンス:
-41.19%
1年 パフォーマンス:
+109.15%
1日の値動き範囲:
$5.61
$5.94
1週間の範囲:
$5.46
$5.99
52週間の値動き範囲:
$2.00
$15.05
Solid Biosciences Inc Stock (SLDB) Company Profile
名前
Solid Biosciences Inc
セクター
電話
617-337-4680
住所
500 RUTHERFORD AVENUE, CHARLESTOWN, MA
Solid Biosciences Inc Stock (SLDB) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-07-15 | アップグレード | JP Morgan | Neutral → Overweight |
| 2024-06-24 | アップグレード | Leerink Partners | Market Perform → Outperform |
| 2024-05-31 | 再開されました | Piper Sandler | Overweight |
| 2024-03-28 | 開始されました | William Blair | Outperform |
| 2024-03-15 | 開始されました | Citigroup | Buy |
| 2024-03-14 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2023-12-08 | 開始されました | H.C. Wainwright | Buy |
| 2021-07-12 | 開始されました | Piper Sandler | Neutral |
| 2021-05-27 | 開始されました | Jefferies | Buy |
| 2021-03-16 | アップグレード | SVB Leerink | Mkt Perform → Outperform |
| 2021-03-09 | 開始されました | Barclays | Overweight |
| 2021-01-08 | アップグレード | Credit Suisse | Underperform → Neutral |
| 2020-07-28 | ダウングレード | SVB Leerink | Outperform → Mkt Perform |
| 2020-05-07 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2019-10-11 | 開始されました | Evercore ISI | Outperform |
| 2019-08-29 | ダウングレード | Citigroup | Neutral → Sell |
| 2019-08-19 | アップグレード | SVB Leerink | Mkt Perform → Outperform |
| 2019-08-16 | アップグレード | Chardan Capital Markets | Neutral → Buy |
| 2019-05-14 | ダウングレード | Credit Suisse | Neutral → Underperform |
| 2019-05-14 | ダウングレード | Goldman | Neutral → Sell |
| 2019-02-08 | アップグレード | Citigroup | Sell → Neutral |
| 2019-02-08 | ダウングレード | SVB Leerink | Outperform → Mkt Perform |
| 2018-11-06 | 開始されました | Citigroup | Sell |
| 2018-09-06 | 開始されました | Credit Suisse | Neutral |
すべてを表示
Solid Biosciences Inc (SLDB) 最新ニュース
Exosome Therapies on the Rise as 70+ Major Companies Driving Development in the Field | DelveInsight - PR Newswire UK
Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Millennium Management LLC Reduces Stake in Solid Biosciences Inc - GuruFocus.com
Sow Good to Hold Third Quarter 2024 Conference Call on Thursday, November 14, 2024 at 10:00 a.m. ET - The Manila Times
Solid Biosciences to Participate at the Truist Securities BioPharma Symposium - GlobeNewswire
Layoff Tracker: Compass Pathways to Lay Off 30% of Employees - BioSpace
Global Exosome Market to Surge at a Tremendous CAGR of ~20% by 2030 | DelveInsight - GlobeNewswire
Duchenne Muscular Dystrophy Therapeutics Market Trends, Growth Insights, and Forecasts 2033 - WhaTech
WRN inhibitor IDE-275 gains IND clearance for phase I study in MSI-high tumors - BioWorld Online
IDEAYA Biosciences Announces IND-Clearance for Werner Helicase Development Candidate IDE275 (GSK959) for a Phase 1 Study in MSI-High Solid Tumors - BioSpace
(SLDB) Proactive Strategies - Stock Traders Daily
Pillar Biosciences Receives CPT® Code for FDA Approved oncoReveal™ CDx Pan-Cancer Solid tumor IVD Kit - PR Newswire
Solid Biosciences CMO sells $18,999 in stock - Investing.com India
Solid Biosciences CMO sells $18,999 in stock By Investing.com - Investing.com Canada
Insider Selling: Solid Biosciences Inc. (NASDAQ:SLDB) Insider Sells 2,923 Shares of Stock - MarketBeat
Kintara Therapeutics Announces 1-for-35 Reverse Stock Split in Connection with the Proposed Merger with TuHURA Biosciences - Quantisnow
Seraxis gains IND clearance for islet replacement therapy - BioWorld Online
(SLDB) Trading Signals - Stock Traders Daily
Solid Biosciences Inc (SLDB) did well last session? - US Post News
Keeping an Eye on Solid Biosciences Inc (SLDB) After Insider Trading Activity - Knox Daily
Cubist Systematic Strategies LLC Sells 74,908 Shares of Huron Consulting Group Inc. (NASDAQ:HURN) - Defense World
Cubist Systematic Strategies LLC Has $368,000 Stock Position in Metropolitan Bank Holding Corp. (NYSE:MCB) - Defense World
Cubist Systematic Strategies LLC Makes New $378,000 Investment in Cryoport, Inc. (NASDAQ:CYRX) - Defense World
Great Lakes Dredge & Dock Co. (NASDAQ:GLDD) Shares Sold by Cubist Systematic Strategies LLC - Defense World
Cubist Systematic Strategies LLC Makes New $362,000 Investment in Anterix Inc. (NASDAQ:ATEX) - Defense World
Aegon Ltd. (NYSE:AEG) Stake Raised by Cubist Systematic Strategies LLC - Defense World
SG Americas Securities LLC Lowers Stock Position in Pool Co. (NASDAQ:POOL) - Defense World
Lindsay Co. (NYSE:LNN) Shares Sold by Cubist Systematic Strategies LLC - Defense World
Cubist Systematic Strategies LLC Sells 23,029 Shares of The St. Joe Company (NYSE:JOE) - Defense World
Solid Biosciences Inc. (NASDAQ:SLDB) Given Consensus Rating of "Buy" by Analysts - MarketBeat
Ono and Ligachem sign licensing agreement for ADC LCB-97 for solid tumors - BioWorld Online
SLDB (Solid Biosciences Inc) may reap gains as insiders became active recently - Knox Daily
Nona Biosciences Enters Strategic Collaboration with OverT Bio to Advance Next-Generation Cell Therapies for Solid Tumors - BioSpace
A Deep Dive into Solid Biosciences Inc (SLDB) Stock Performance - The InvestChronicle
Solid Biosciences Inc. (NASDAQ:SLDB) Shares Acquired by Millennium Management LLC - MarketBeat
MBX Biosciences outlook solid with JPMorgan's overweight rating, eyes key catalysts in next 12 months - Investing.com
Marshall Wace LLP Invests $1.55 Million in Solid Biosciences Inc. (NASDAQ:SLDB) - MarketBeat
Renaissance Technologies LLC Acquires 208,793 Shares of Solid Biosciences Inc. (NASDAQ:SLDB) - MarketBeat
(SLDB) Investment Analysis - Stock Traders Daily
Fresh Study Reveals the Duchenne Muscular Dystrophy Market Insights, Demand, and Forecast to 2033 - WhaTech
Solid Biosciences' SWOT analysis: DMD therapy stock faces pivotal data - Investing.com
Deerfield Management Company L.P. Series C Lowers Position in Solid Biosciences Inc. (NASDAQ:SLDB) - MarketBeat
Duchenne Muscular Dystrophy Treatment Drugs, Clinical Trials, Pipeline Insights and Companies 2024 - The Globe and Mail
Is Solid Power, Inc. (SLDP) the Most Promising EV Battery Stock According to Analysts? - Insider Monkey
The Trailer for Ryan Coogler’s Horror Film Sinners Is Appealingly Mysterious - Reactor
Sinners: Ryan Coogler’s Latest Gets a Thrilling First Trailer - Cinelinx
Solid Power, Inc. (NASDAQ:SLDP) Stock Position Reduced by Sagefield Capital LP - Defense World
Inspire Investing LLC Boosts Stake in Silicon Laboratories Inc. (NASDAQ:SLAB) - Defense World
The First Trailer For Ryan Coogler's Sinners Drops Tomorrow - Bleeding Cool News
Solid Biosciences to Participate at Chardan’s 8th Annual Genetic Medicines Conference - GlobeNewswire
Lysosomal Disease Treatment Market Size, Analysis, Trends, Opportunities 2024-2033 - WhaTech
Solid Biosciences Inc (SLDB) 財務データ
収益
当期純利益
現金流量
EPS
Solid Biosciences Inc (SLDB) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Kahn Clare | Director |
Jun 07 '24 |
Buy |
7.67 |
1,100 |
8,442 |
1,100 |
| Ganot Ilan | Director |
May 02 '24 |
Sale |
10.33 |
462 |
4,772 |
9,507 |
| Ganot Ilan | Director |
Jan 29 '24 |
Sale |
7.99 |
139 |
1,111 |
8,416 |
| PERCEPTIVE ADVISORS LLC | Director |
Jan 11 '24 |
Buy |
5.53 |
3,410,713 |
18,861,243 |
6,833,539 |
| RA CAPITAL MANAGEMENT, L.P. | Director |
Jan 11 '24 |
Buy |
5.53 |
904,160 |
5,000,005 |
4,192,216 |
| Tan Kevin | CFO & Treasurer |
Jan 09 '24 |
Sale |
8.20 |
3,935 |
32,267 |
9,308 |
| Ganot Ilan | Director |
Jan 03 '24 |
Sale |
5.30 |
1,142 |
6,052 |
8,167 |
| Cumbo Alexander | President and CEO |
Dec 04 '23 |
Sale |
2.77 |
11,757 |
32,516 |
17,439 |
| Howton David T | Chief Operating Officer |
Dec 04 '23 |
Sale |
2.78 |
5,367 |
14,920 |
7,684 |
| Herzich Paul | Chief Technology Officer |
Dec 04 '23 |
Sale |
2.77 |
2,968 |
8,232 |
4,270 |
2.02%
0.47%
大文字化:
|
ボリューム (24 時間):